Doxorubicin Hydrochloride Injection, Suspension, Liposomal
Product Images NDC 62332-525

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 62332-525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxorubicin-10ml-carton (Doxorubicin 10ml Carton)

Packaging label for doxorubicin hydrochloride liposome injection, 20 mg/10 mL (2 mg/mL), manufactured by Alembic Pharmaceuticals Inc. The label indicates it is for intravenous infusion, single-dose vial, with storage instructions to refrigerate at 2° to 8°C and not freeze. The label highlights the liposomal formulation with a warning not to substitute for doxorubicin hydrochloride and includes a list of excipients and cytotoxicity warning.*

FDA Label Image

Doxorubicin-10ml-vial (Doxorubicin 10ml Vial)

Label for Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) single-dose vial. It specifies intravenous use after dilution, includes a warning not to substitute this liposomal formulation for doxorubicin hydrochloride, and provides manufacturer info for Alembic Pharmaceuticals Inc., with storage instructions and lot/expiration placeholders.*

FDA Label Image

Doxorubicin-25ml-carton (Doxorubicin 25ml Carton)

Packaging label for DOXOrubicin Hydrochloride Liposome Injection, 50 mg/25 mL (2 mg/mL) by Alembic Pharmaceuticals Inc. The label indicates it is a liposomal formulation for intravenous infusion only after dilution, with storage instructions to refrigerate at 2° to 8°C (36° to 46°F) and not to freeze. The vial size is 25 mL, single-dose. It includes a warning not to substitute this liposomal formulation for doxorubicin hydrochloride.*

FDA Label Image

Oxorubicin-25ml-vial (Doxorubicin 25ml Vial)

Label for Doxorubicin Hydrochloride Liposome Injection, 50 mg/25 mL (2 mg/mL) in a 25 mL single-dose vial by Alembic Pharmaceuticals Inc. The label includes storage instructions (refrigerate at 2° to 8°C), dosage note, and warnings that it is cytotoxic and for intravenous infusion only after dilution. The label also states it should be used with 5% Dextrose Injection and not to substitute for doxorubicin hydrochloride.*

FDA Label Image

Doxorubicin-figure-1 (Doxorubicin Figure 1)

A Kaplan-Meier survival curve depicting the percent of subjects progression-free over time in months comparing treatments with Doxorubicin HCl plus Bortezomib versus Bortezomib alone. The plot includes survival probability percentages on the y-axis and time in months on the x-axis, with risk table data showing number of subjects at risk at various time points. The graph demonstrates a higher progression-free survival for Doxorubicin HCl plus Bortezomib.*

FDA Label Image

Doxorubicin-hspe (Doxorubicin Hspe)

Chemical structure diagram showing the molecular structure of doxorubicin hydrochloride with labeled components and notation for variable chain lengths (m, n = 14 or 16).*

FDA Label Image

Doxorubicin-mpeg-dspe (Doxorubicin Mpeg Dspe)

Chemical structure of doxorubicin hydrochloride liposomal formulation, showing phospholipid components with associated fatty acid chains and sodium ion.*

FDA Label Image

Doxorubicin-pegylated-liposome (Doxorubicin Pegylated Liposome)

An illustration depicting the structure of a liposomal formulation of doxorubicin hydrochloride. It shows three labeled components: MPEG-DSPE coating on the outer surface, a liposomal bilayer beneath it, and an aqueous core containing entrapped doxorubicin hydrochloride.*

FDA Label Image

Doxorubicin-structure. (Doxorubicin Structure)

Chemical structure diagram of doxorubicin hydrochloride showing its molecular arrangement, including rings, hydroxyl groups, methoxy group, amino sugar moiety, and hydrochloride salt component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.